California advocates for the legalization of psychedelics are exploring a potential state ballot measure for 2026 that would legalize the use of substances like psilocybin and MDMA, according to a report by KQED. This consideration comes after recent legislative efforts to legalize psychedelic treatment centers, spearheaded by State Senator Scott Weiner (D), failed to pass.
Sen. Weiner, who has been a vocal supporter of psychedelic reform, remains optimistic about the future of this initiative. “We are not giving up, whether that means introducing a new bill or ballot measure, this issue is not going away. We know these substances are helping people turn their lives around,” Weiner told KQED.
Governor Gavin Newsom (D) previously vetoed a proposal to decriminalize certain psychedelic substances, including mescaline, DMT, psilocybin, and psilocin, in 2023. He requested that lawmakers focus on the therapeutic applications of these substances in future legislation.
The specifics of the potential 2026 ballot measure are still under discussion. Advocates are debating whether to focus solely on the therapeutic use of psychedelics, such as magic mushrooms, or to push for a broader decriminalization.
Scientific research has increasingly shown the benefits of psychedelics in treating mental health issues that are resistant to other forms of treatment. Studies have demonstrated the promise of substances like MDMA and psilocybin in addressing severe mental health conditions.
Oregon made history in 2020 by becoming the first state to legalize therapeutic psychedelics. However, the success of their program has been mixed, providing a learning opportunity for other states considering similar measures.
California’s potential move towards legalization reflects a growing national interest in the therapeutic and recreational use of psychedelics. If successful, it could pave the way for significant changes in drug policy across the United States.
For the latest updates on cannabis business news, subscribe to our daily newsletter.
